Tempus ai stock forecast 2025 technical traders eye a golden cross
Technical traders eye a golden cross pattern in Tempus AI stock forecast 2025 price charts. Momentum indicators point toward sustained buying pressure if daily volume remains above 2 million shares. Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 26 best rare earth metal stocks of the very few that mine this essential strategic resource. Strategic Collaborations With AstraZeneca & Pathos : Tempus signed a three-year, $200 million data and modeling license agreement with AstraZeneca (AZN) and Pathos to build a multimodal foundation model in oncology, leveraging more than 300 petabytes of rich multimodal healthcare data that Tempus has built over the past decade. Notably, the deal raised the total remaining contract value to greater than $1 billion as of April-end. Management guidance indicates double-digit customer base growth, translating into potentially higher recurring revenue streams and stronger quarter-over-quarter performance.
Return this item for free
We offer easy, convenient returns with at least one free return option: no shipping charges. All returns must comply with our returns policy.
Learn more about free returns.- Go to your orders and start the return
- Select your preferred free shipping option
- Drop off and leave!